Author pages are created from data sourced from our academic publisher partnerships and public sources.
Intracoronary Injection of CD133-Positive Enriched Bone Marrow Progenitor Cells Promotes Cardiac Recovery After Recent Myocardial Infarction: Feasibility and Safety
Background—Bone marrow CD133-postive (CD133+) cells possess high hematopoietic and angiogenic capacity. We tested the feasibility, safety, and functional effects of the use of enriched CD133+… Expand
Cardiac Recovery After Recent Myocardial Infarction : Feasibility and Safety Intracoronary Injection of CD 133-Positive Enriched Bone Marrow Progenitor Cells
Jozef Bartunek, Marc Vanderheyden, Bart Vandekerckhove, Samer Mansour, Bernard De Promotes Cardiac Recovery After Recent Myocardial Infarction: Feasibility and Safety Intracoronary Injection of… Expand
Viable CD34+ stem cell content of a cord blood graft: which measurement performed before transplantation is most representative?
BACKGROUND Patient survival in allogeneic cord blood transplantation is critically dependent on total nucleated cell (TNC) count or total CD34+ cell count per kg of body weight. Theoretically, viable… Expand
Selecting cord blood units for storage by CD34+ cell counts.
Selection of Cord Blood Units Based on CD34+ Cells for Storage in Cord Blood Bank.
Over 170 000 cord blood units are stored worldwide. For the majority of patients in need of an allogeneic donor, a cord blood unit can be found which is identical or has less than 2 HLA mismatches.… Expand